Botanical Safety Consortium Resources

Curated references, definitions, and links that support BSC work.

01

BSC Glossary

Adulterate+

Adulterate: To make unsafe or impure by using contaminated or unneeded ingredients; using a strength or quality that is less than claimed; leaving out or substituting key ingredients; or using inferior manufacturing, processing, packaging, or storage procedures.1

Also, intentional economically motivated adulteration has been defined as the fraudulent addition of non-authentic substances or removal or replacement of authentic substances without the purchaser’s knowledge for economic gain of the seller.2

1 “Dictionary of Dietary Supplement Terms.” NIH Office of Dietary Supplements, U.S. Department of Health and Human Services.

2 Food Fraud Mitigation Guidance. In: FCC10. Rockville, MD: United States Pharmacopeial Convention; 2017:1586-1621.

Botanical or herbal+

A plant, alga, or fungus; a part of a plant, alga, or fungus (e.g., bark, leaves, stems, roots, flowers, fruits, seeds, berries, or parts thereof); or an exudate (secretion) of a plant, alga, or fungus.3

3 Dietary Supplements: New Dietary Ingredient Notifications and Related Issues — Guidance for Industry (Draft). U.S. Food and Drug Administration.

Botanical ingredient+

An ingredient of a dietary supplement, personal care, cosmetic, or food product derived from plants, algae, or fungi. Botanical ingredients can be whole, cut, or powdered, or in the form of an extract after further processing using appropriate solvents and methods.

Botanicokinetics+

The quantitative study of the absorption, distribution, metabolism, and excretion of botanicals (and their constituents) in living things.4

4 Defined by the Botanical Safety Consortium.

Botanical raw material+

Whole or physically processed (e.g., cleaned, frozen, dried, or sliced) parts of a single species of plant or a fresh or processed alga or fungus.3 Also referred to as raw agricultural commodities or crude material from which botanical ingredients are made.

3 Dietary Supplements: New Dietary Ingredient Notifications and Related Issues — Guidance for Industry (Draft), FDA.

Botanicodynamics+

The study of the actions and interactions of botanicals (and their constituents) within the organism and describes processes at organ, tissue, cellular, and molecular levels.4

4 Defined by the Botanical Safety Consortium.

Component+

A substance that is part of a mixture. Includes substances that cannot be isolated from the whole, as well as those that can. Once isolated, a component of a mixture is also a constituent (see Constituent).3

For example, once combined, hops and valerian extracts cannot be separated though individual constituents can be isolated. The term component also has an FDA regulatory dietary supplement definition meaning any substance used in manufacturing a finished dietary supplement.

3 Dietary Supplements: New Dietary Ingredient Notifications and Related Issues — Guidance for Industry (Draft), FDA.

Constituent+

An article that is a physical part of the whole and can be isolated from the whole.3 Also defined as a component, part, or ingredient of a larger whole. For example, valerenic acid and valepotriate are constituents of the dietary supplement valerian.1 Phytochemicals are botanical constituents.

1 “Dictionary of Dietary Supplement Terms.” NIH Office of Dietary Supplements.

3 Dietary Supplements: New Dietary Ingredient Notifications and Related Issues — Guidance for Industry (Draft), FDA.

Dietary ingredient+

An ingredient of a dietary supplement that is (A) a vitamin, (B) a mineral, (C) an herb or other botanical, (D) an amino acid, (E) a dietary substance for use by man to supplement the diet by increasing the total dietary intake, or (F) a concentrate, metabolite, constituent, extract, or combination of any ingredient described in (A) through (E).3

3 Dietary Supplements: New Dietary Ingredient Notifications and Related Issues — Guidance for Industry (Draft), FDA.

Dietary substance+

A substance that is commonly used as human food or drink.3

3 Dietary Supplements: New Dietary Ingredient Notifications and Related Issues — Guidance for Industry (Draft), FDA.

Dietary supplement+

A product that is intended to supplement the diet. A dietary supplement contains one or more dietary ingredients (including vitamins, minerals, herbs or other botanicals, amino acids, and other substances) or their components; is intended to be taken by mouth as a pill, capsule, tablet, or liquid; and is identified on the front label of the product as being a dietary supplement.1,5

1 “Dictionary of Dietary Supplement Terms.” NIH Office of Dietary Supplements.

5 “Office of Dietary Supplements — Background Information: Botanical Dietary Supplements.” NIH ODS.

Extract+

A product (ingredient) consisting of a solvent (menstruum) combined with a dietary substance or botanical biomass by a process that physically separates constituents from the dietary substance or botanical and dissolves them into the solvent. The extract can be further concentrated through drying to a dry powder or semi-solid form.3

3 Dietary Supplements: New Dietary Ingredient Notifications and Related Issues — Guidance for Industry (Draft), FDA.

Interaction+

A change in the way a finished product acts in the body when taken with certain other supplements, medicines, or foods, or when taken with certain medical conditions. Interactions may cause the product to be more or less effective, or cause effects on the body that are not expected.1

1 “Dictionary of Dietary Supplement Terms.” NIH Office of Dietary Supplements.

Metabolism+

All chemical changes that take place in a cell or an organism. These changes produce energy and basic materials needed for important life processes.1

1 “Dictionary of Dietary Supplement Terms.” NIH Office of Dietary Supplements.

Pharmacognosy+

The study of natural product molecules that are useful for their medicinal, ecological, gustatory, or other functional properties.

Phytochemical+

Chemical constituents produced by plants, sometimes referred to as primary metabolites when directly involved in the normal growth, development, or reproduction of the organism, and secondary metabolites when not.

Secondary Metabolite+

Chemical constituents produced by plants not directly involved in the normal growth, development, or reproduction of the organism. See Phytochemical.6

6 Böttger A, Vothknecht U, Bolle C, Wolf A. (2018). Plant Secondary Metabolites and Their General Function in Plants. Springer.

02

BSC-related Articles

Nyirenda et al., 2025 An exploratory evaluation of the — Pharmaceutical Biology (opens in a new tab) Mitchell et al., 2025 From Vision to Reality: Five Years — Pharmaceutical Biology (opens in a new tab) van Kleef et al., 2025 Dose-response assessment of neuroactive — Pharmaceutical Biology (opens in a new tab) Krzykwa et al., 2025 Developing an approach for evaluating — Front. Toxicol. (opens in a new tab) Sica et al., 2025 Multi-detector approach for botanical extracts — Anal Bioanal Chem (opens in a new tab) Liu et al., 2025 ECCS models for botanical constituent clearance — TAAP (opens in a new tab) Witt et al., 2025 Genotoxicity screening strategy — FCT (opens in a new tab) Roe et al., 2024 Hepatotoxicity & interactions — J Diet Suppl (opens in a new tab) Koturbash et al., 2024 Liver injury & interactions — Regul Toxicol Pharmacol (opens in a new tab) Muchiri et al., 2024 Milk thistle standardization — JASMS (opens in a new tab) Kanungo et al., 2024 Neurotoxicity screening tools — EODMT (opens in a new tab) Liu et al., 2024 Physchem & PK predictions — J Appl Toxicol (opens in a new tab) Zeiger et al., 2024 Ames test reproducibility — EMM (opens in a new tab) Waidyanatha et al., 2024 Selecting & sourcing botanicals — FCT (opens in a new tab) van Kleef et al., 2024 MEA neuroactivity screening — FCT (opens in a new tab) Patel et al., 2023 Improving rigor & utility — Regul Toxicol Pharmacol (opens in a new tab) Smith et al., 2023 Herb–ritonavir interactions — Front Pharmacol (opens in a new tab) Pearson et al., 2022 Nephrotoxicity tools — Curr Opin Toxicol (opens in a new tab) Mitchell et al., 2021 BSC overview — Regul Toxicol Pharmacol (opens in a new tab) Roe et al., 2019 BSC introduction — Applied In Vitro Toxicol (opens in a new tab) Galli et al., 2019 Consensus approach — Toxicol Lett (opens in a new tab)